
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-04-30 | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $4.4M | $8.4M | $7.7M | $7.6M | $5.8M | |
Other Inc / (Exp) | -- | -- | $1M | $1.8M | $314K | |
Operating Expenses | $5.7M | $12.4M | $15M | $9.4M | $7.3M | |
Operating Income | -$5.7M | -$12.4M | -$15M | -$9.4M | -$7.3M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$5.7M | -$12.4M | -$13.9M | -$7.6M | -$6.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$438.2K | -- | -- | -- | -- | |
Net Income to Company | -$5.2M | -$12.4M | -$13.9M | -$7.6M | -$6.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$5.2M | -$12.4M | -$13.9M | -$7.6M | -$6.9M | |
Basic EPS (Cont. Ops) | -$3.17 | -$3.80 | -$1.92 | -$0.90 | -$0.74 | |
Diluted EPS (Cont. Ops) | -$3.17 | -$3.80 | -$1.92 | -$0.90 | -$0.74 | |
Weighted Average Basic Share | $2.3M | $4.7M | $7.3M | $8.4M | $9.4M | |
Weighted Average Diluted Share | $2.3M | $4.7M | $7.3M | $8.4M | $9.4M | |
EBITDA | -$5.7M | -$12.4M | -$14.9M | -$9.3M | -$7.2M | |
EBIT | -$5.7M | -$12.4M | -$15M | -$9.4M | -$7.3M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -$5.7M | -$12.4M | -$15M | -$9.4M | -$7.3M | |
Operating Income (Adjusted) | -$5.7M | -$12.4M | -$15M | -$9.4M | -$7.3M |
Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $2.4M | $2.7M | $1.9M | $1.1M | $4.3M | |
Other Inc / (Exp) | -- | -- | $374.4K | -$418.6K | -$1.3M | |
Operating Expenses | $3.7M | $4.3M | $2.3M | $1.3M | $5.1M | |
Operating Income | -$3.7M | -$4.3M | -$2.3M | -$1.3M | -$5.1M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$3.7M | -$4.3M | -$1.9M | -$1.7M | -$6.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$3.7M | -$4.3M | -$1.9M | -$1.7M | -$6.4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$3.7M | -$4.3M | -$1.9M | -$1.7M | -$6.4M | |
Basic EPS (Cont. Ops) | -$0.67 | -$0.61 | -$0.23 | -$0.18 | -$0.54 | |
Diluted EPS (Cont. Ops) | -$0.67 | -$0.61 | -$0.23 | -$0.18 | -$0.54 | |
Weighted Average Basic Share | $5.5M | $7.1M | $8.4M | $9.3M | $11.8M | |
Weighted Average Diluted Share | $5.5M | $7.1M | $8.4M | $9.3M | $11.8M | |
EBITDA | -$3.7M | -$4.3M | -$2.2M | -$1.3M | -$5.1M | |
EBIT | -$3.7M | -$4.3M | -$2.3M | -$1.3M | -$5.1M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -$3.7M | -$4.3M | -$2.3M | -$1.3M | -$5.1M | |
Operating Income (Adjusted) | -$3.7M | -$4.3M | -$2.3M | -$1.3M | -$5.1M |
Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $7.3M | $7.8M | $7.7M | $6.5M | $9M | |
Other Inc / (Exp) | -- | -- | $1.5M | $1.3M | -$3.8M | |
Operating Expenses | $10.5M | $15.1M | $10M | $8.1M | $11.1M | |
Operating Income | -$10.5M | -$15.1M | -$10M | -$8.1M | -$11.1M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$10.5M | -$15.1M | -$7.5M | -$6.7M | -$14.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$219.1K | -- | -- | -- | -- | |
Net Income to Company | -$10.3M | -$15.1M | -$7.5M | -$6.7M | -$14.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$10.3M | -$15.1M | -$7.5M | -$6.7M | -$14.8M | |
Basic EPS (Cont. Ops) | -$4.17 | -$1.74 | -$0.89 | -$0.73 | -$1.36 | |
Diluted EPS (Cont. Ops) | -$4.17 | -$1.74 | -$0.89 | -$0.73 | -$1.36 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$10.5M | -$15M | -$9.9M | -$8M | -$11M | |
EBIT | -$10.5M | -$15.1M | -$10M | -$8.1M | -$11.1M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -$10.5M | -$15.1M | -$10M | -$8.1M | -$11.1M | |
Operating Income (Adjusted) | -$10.5M | -$15.1M | -$10M | -$8.1M | -$11.1M |
Period Ending | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | 2026-01-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $5.8M | $5.7M | $4.6M | $7.9M | -- | |
Other Inc / (Exp) | -- | $1.5M | $1.1M | -$3.1M | -- | |
Operating Expenses | $12.2M | $7.3M | $6M | $9.8M | -- | |
Operating Income | -$12.2M | -$7.3M | -$6M | -$9.8M | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$12.2M | -$5.7M | -$4.8M | -$12.8M | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$12.2M | -$5.7M | -$4.8M | -$12.8M | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$12.2M | -$5.7M | -$4.8M | -$12.8M | -- | |
Basic EPS (Cont. Ops) | -$1.72 | -$0.69 | -$0.52 | -$1.14 | -- | |
Diluted EPS (Cont. Ops) | -$1.72 | -$0.69 | -$0.52 | -$1.14 | -- | |
Weighted Average Basic Share | $21.3M | $25.1M | $27.9M | $33.2M | -- | |
Weighted Average Diluted Share | $21.3M | $25.1M | $27.9M | $33.2M | -- | |
EBITDA | -$12.1M | -$7.2M | -$5.9M | -$9.8M | -- | |
EBIT | -$12.2M | -$7.3M | -$6M | -$9.8M | -- | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -$12.2M | -$7.3M | -$6M | -$9.8M | -- | |
Operating Income (Adjusted) | -$12.2M | -$7.3M | -$6M | -$9.8M | -- |
Period Ending | 2020-04-30 | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $2.7M | $13.6M | $9.1M | $7.8M | $5.6M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $212.7K | $430.4K | $787.9K | $610.1K | $948.8K | |
Total Current Assets | $3.2M | $14.1M | $9.9M | $8.4M | $6.5M | |
Property Plant And Equipment | $6.3M | $16.5M | $16.8M | $14.9M | $14.9M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $355.6K | $718.5K | $832.5K | $857.5K | $1.2M | |
Total Assets | $9.8M | $31.3M | $27.5M | $24.2M | $22.6M | |
Accounts Payable | $154.4K | $619K | $1.1M | -- | -- | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | $55.6K | $32.1K | $57.5K | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $157.8K | $619K | $1.1M | $378.8K | $452.8K | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $326.2K | $823.7K | $4.3M | $5.3M | $5.1M | |
Common Stock | $2.9K | $7.1K | $8.4K | $9.3K | $10.7K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $9.5M | $30.5M | $23.2M | $18.9M | $17.5M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $9.5M | $30.5M | $23.2M | $18.9M | $17.5M | |
Total Liabilities and Equity | $9.8M | $31.3M | $27.5M | $24.2M | $22.6M | |
Cash and Short Terms | $2.7M | $13.6M | $9.1M | $7.8M | $5.6M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $14M | $3.7M | $5.3M | $2.6M | $9.1M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $368.1K | $400.9K | $463.9K | $395.2K | $884.2K | |
Total Current Assets | $14.6M | $4.1M | $5.7M | $3M | $10M | |
Property Plant And Equipment | $16.5M | $16.8M | $14.9M | $14.9M | $14.9M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $389.6K | $832.5K | $832.5K | $909.3K | $1.1M | |
Total Assets | $31.5M | $21.7M | $21.5M | $18.9M | $26M | |
Accounts Payable | $572.2K | -- | -- | -- | $581.7K | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | $52K | $40.4K | $56.6K | $43.7K | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $572.2K | $1.4M | $515.4K | $288.7K | $800.4K | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $766.9K | $1.7M | $2.5M | $4.2M | $8.5M | |
Common Stock | $6.7K | $7.1K | $8.4K | $9.3K | $12.4K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $30.7M | $20M | $19M | $14.7M | $17.5M | |
Total Liabilities and Equity | $31.5M | $21.7M | $21.5M | $18.9M | $26M | |
Cash and Short Terms | $14M | $3.7M | $5.3M | $2.6M | $9.1M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-04-30 | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$5.2M | -$12.4M | -$13.9M | -$7.6M | -$6.9M | |
Depreciation & Amoritzation | $10.7K | $22.9K | $74.8K | $89K | $88.2K | |
Stock-Based Compensation | $1.3M | $3.6M | $1.7M | $1.3M | $593.6K | |
Change in Accounts Receivable | -$219.1K | $219.1K | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$3.9M | -$8.6M | -$12.6M | -$8.7M | -$7.1M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | $159.1K | $2.5M | -$179K | $2.6M | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $4.3M | $17M | $8.2M | $4.8M | $4.8M | |
Beginning Cash (CF) | $2.2M | $2.7M | $13.6M | $9.1M | $7.8M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $552.8K | $10.9M | -$4.5M | -$1.3M | -$2.2M | |
Ending Cash (CF) | $2.7M | $13.6M | $9.1M | $7.8M | $5.6M | |
Levered Free Cash Flow | -$3.9M | -$8.6M | -$12.8M | -$8.9M | -$7.1M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$10.3M | -$15.1M | -$7.5M | -$6.7M | -$14.8M | |
Depreciation & Amoritzation | $20.6K | $59.4K | $89.2K | $87.7K | $88.9K | |
Stock-Based Compensation | $3.1M | $2.1M | $1.3M | $793.7K | $2M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$6.7M | -$12M | -$9.2M | -$7.5M | -$9M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | $2.5M | -$179K | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $12.8M | -$10.3M | $1.6M | -$2.6M | $6.5M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$6.8M | -$12.2M | -$9.4M | -$7.5M | -$9M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.